Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients

Yonghui Hu, Zhiyue Yan, Congqing Pan NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence: Cong...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hu Y, Yan Z, Pan C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/79957531def94a77b139f176bfc52497
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:79957531def94a77b139f176bfc52497
record_format dspace
spelling oai:doaj.org-article:79957531def94a77b139f176bfc524972021-12-02T16:02:31ZAssociations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients1178-7007https://doaj.org/article/79957531def94a77b139f176bfc524972021-06-01T00:00:00Zhttps://www.dovepress.com/associations-of-thyroid-hormone-levels-and-macrovascular-complications-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Yonghui Hu, Zhiyue Yan, Congqing Pan NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence: Congqing PanNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, People’s Republic of ChinaTel +86-13920423976Fax +86-22-59560475Email profpancq@163.comPurpose: The purpose of this study is to evaluate whether thyroid hormone in euthyroid patients with type 2 diabetes mellitus (T2DM) is associated with macrovascular complications.Patients and Methods: The authors examined 311 patients enrolled from February 2019 to December 2019 in Tianjin Medical University Chu Hsien-I Memorial Hospital. A medical record review enabled the collection of demographic and anthropometric information. We classified the patients into two groups based on the echocardiography and vascular ultrasonography results, namely, non-macrovascular complications (n=131) group and macrovascular complications (n=180) group. Odds ratios (OR) and 95% confidence intervals (CI) were calculated, adjusting for potential confounders, the prevalence of macrovascular complications was determined using multivariate logistic regression.Results: A significant association was observed for diabetic macrovascular complications with normal free triiodothyronine (FT3) (OR=0.534, 95% CI 0.358– 0.796, p = 0.002) and free thyroxine (FT4) (OR= 0.844, 95% CI 0.760– 0.937, p = 0.001). Nevertheless, there was no evidence of any association between thyroid-stimulating hormone (TSH) and the development of diabetic macrovascular complications. When stratified by the body mass index (BMI), a similar relationship existed with the overall results. The positive association remained in restricted analyses involving only patients with HbA1c abnormalities.Conclusion: Overweight or obese T2DM patients are at high risk due to the implicit association between low but clinically normal thyroid hormone levels and elevated risk of macrovascular complications. However, there were no statistically significant associations between TSH and diabetic macrovascular complications.Keywords: macrovascular complications, T2DM, thyroid hormone, type 2 diabetes mellitusHu YYan ZPan CDove Medical Pressarticlemacrovascular complicationst2dmthyroid hormonetype 2 diabetes mellitusSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 2683-2691 (2021)
institution DOAJ
collection DOAJ
language EN
topic macrovascular complications
t2dm
thyroid hormone
type 2 diabetes mellitus
Specialties of internal medicine
RC581-951
spellingShingle macrovascular complications
t2dm
thyroid hormone
type 2 diabetes mellitus
Specialties of internal medicine
RC581-951
Hu Y
Yan Z
Pan C
Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
description Yonghui Hu, Zhiyue Yan, Congqing Pan NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence: Congqing PanNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, People’s Republic of ChinaTel +86-13920423976Fax +86-22-59560475Email profpancq@163.comPurpose: The purpose of this study is to evaluate whether thyroid hormone in euthyroid patients with type 2 diabetes mellitus (T2DM) is associated with macrovascular complications.Patients and Methods: The authors examined 311 patients enrolled from February 2019 to December 2019 in Tianjin Medical University Chu Hsien-I Memorial Hospital. A medical record review enabled the collection of demographic and anthropometric information. We classified the patients into two groups based on the echocardiography and vascular ultrasonography results, namely, non-macrovascular complications (n=131) group and macrovascular complications (n=180) group. Odds ratios (OR) and 95% confidence intervals (CI) were calculated, adjusting for potential confounders, the prevalence of macrovascular complications was determined using multivariate logistic regression.Results: A significant association was observed for diabetic macrovascular complications with normal free triiodothyronine (FT3) (OR=0.534, 95% CI 0.358– 0.796, p = 0.002) and free thyroxine (FT4) (OR= 0.844, 95% CI 0.760– 0.937, p = 0.001). Nevertheless, there was no evidence of any association between thyroid-stimulating hormone (TSH) and the development of diabetic macrovascular complications. When stratified by the body mass index (BMI), a similar relationship existed with the overall results. The positive association remained in restricted analyses involving only patients with HbA1c abnormalities.Conclusion: Overweight or obese T2DM patients are at high risk due to the implicit association between low but clinically normal thyroid hormone levels and elevated risk of macrovascular complications. However, there were no statistically significant associations between TSH and diabetic macrovascular complications.Keywords: macrovascular complications, T2DM, thyroid hormone, type 2 diabetes mellitus
format article
author Hu Y
Yan Z
Pan C
author_facet Hu Y
Yan Z
Pan C
author_sort Hu Y
title Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
title_short Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
title_full Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
title_fullStr Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
title_full_unstemmed Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
title_sort associations of thyroid hormone levels and macrovascular complications in euthyroid type 2 diabetic patients
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/79957531def94a77b139f176bfc52497
work_keys_str_mv AT huy associationsofthyroidhormonelevelsandmacrovascularcomplicationsineuthyroidtype2diabeticpatients
AT yanz associationsofthyroidhormonelevelsandmacrovascularcomplicationsineuthyroidtype2diabeticpatients
AT panc associationsofthyroidhormonelevelsandmacrovascularcomplicationsineuthyroidtype2diabeticpatients
_version_ 1718385281042743296